Wrinkles

... Treating Migraines with Botox Expressindia Financial Express Indian Express Screen Web NEWSLINES More Cities Ahmedabad Chandigarh Delhi Kolkata Lucknow Ludhiana Mumbai Pune Cities Home NL ARCHIVE Search by Date SERVICES Matrimonials New friendships, romance...

Free Money Transfers to India Send Gifts Online Personalised Predictions CHANNELS Astrology Shopping Express Classifieds Express Estates Express Money Express Travel GROUP SITES Expressindia The Indian Express The Financial Express Screen Kashmir Live Express Cricket Loksatta Lokprabha North American Edition [Print] COLUMNISTS The Indian Express The Financial Express SUBSCRIPTIONS Free Newsletter Wireless Express SYNDICATIONS RSS Feeds Home Body & MindThursday , February 02, 2006 Page 1 All Headlines BODY & MIND Treating Migraines with Botox Express Features Service The use of Botox for the prevention of migraine came about accidentally.

Plastic surgeons have been using Botox to treat wrinkles for a few years.

Several patients who also happened to have migraines reported that their migraines improved following the injection of Botox into forehead and brow muscles.

One possibility is that muscle tension may act as a trigger for migraine in the same way that light and odours do.

By reducing muscle tension, Botox...

... Profits Are Only Skin Deep (Candela)| SmartMoney.com #tooltip{z-index:5000;border:1px solid #666;background-color:#deefff;padding:2px;display:none;position:absolute;top:250px;left:50px;width:165px;} .dqStyle{color:black;font-size:10px;font-family:verdana;font-weight: bold;} .dqNoChg{color:black;} .dqUp{color:green;} .dqDn{color:red;} .ticNoChg{background-color:#FFFFFF;} .ticUp{background-color: #CCFFCC;} .ticDn{background-color:#FFE4E1;} Wednesday February 1, 2006 7:00 PM ETU.S.

Markets are Closed Search (choose an option below) Quote Charting Earnings Ratings Competition Financials Profile Key Statistics Insiders Site Search News (Enter Symbol) advanced search .mainTab{cursor:hand;height:16px;background-color:#003366;}.altMainTab{cursor:hand;height:16px;background-color:#003366;}a.mainTabText{color:#FFFFFF;text-decoration:none;font-weight:bold;font-size:10px;font-family:Verdana;}a.expMainText{color:#003366;text-decoration:none;font-weight:bold;font-size:10px;font-family:Verdana;}a.expMenuText{color:#000000;font-size:10px;font-family:Verdana;}a.expMenuText:hover{text-decoration:none;font-size:10px;font-family:Verdana;}.rtTabLine{background-color:#00274E;}#smLeftSubMenu .subMenuTab{background-color:#DEEFFF;border: solid 1px #00274E;position:absolute;visibility:hidden;width:160px;}#smLeftSubMenu .subMenuText{cursor:hand;height:11px;color:#003366;text-decoration:none;font-size:10px;font-family:Verdana;font-weight:bold;padding-left:5px;padding-right:4px;padding-top:1px;padding-...

... Raising the cash for hair raising Take me to...

Site map : Bookmark Business FREE web feed Manchester Evening News Business User CommentsArchive NewsSportFootballBusinessPersonal FinancePhoto GalleriesPostbagIn TouchCrosswordAudio & VideoKilimanjaro 2005About UsContact Us Manchester Online HomeNewsM.E.N.

TodaySportFootballEntertainmentShowbizHealth and BeautyBusinessJobsAdvertise Your JobCV-StationHomesFood & DrinkTravelMotorsCompetitionsClassifiedsGamesPersonal FinanceFamily NoticesPublic TransportHotelsDatingMancuniansBuild A SiteTourist GuideLocal PressWeatherOnline ShopAdvertising home business Email to a friend Your comments Wednesday, 1st February 2006 Raising the cash for hair raising Sarah WaltersA COMPANY which is developing treatments for baldness and wrinkles was making its debut on the stock market today.Intercytex Group, which is based in Manchester, has raised £15m to fund research, of which £10.8m has come from new investors and the rest from existing shareholders.

The shares were priced at 108p, valuing the business at £60m.The company, which employs more than 50 people at its hub in the south of the city, hopes to use the capital to take its pioneering hair-cloning treatment, dubbed ICX-TRC, to the next stage of its clinical trials.

Richard Moulson, Intercytex's chief financial officer, said: "We have invested in and developed some ground-breaking products in cell therapy."The group's admission to AIM will enable us to r...